Phase 4 Vasculitis Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen300 enrolled76 locationsNCT06072482
Recruiting
Phase 4
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India585 enrolled12 locationsNCT06676384
Recruiting
Phase 4
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
ANCA Associated Vasculitis (AAV)
Chiba University160 enrolled22 locationsNCT06611696
Recruiting
Phase 4
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Maintenance TherapyANCA-associated Vasculitis
Chinese SLE Treatment And Research Group40 enrolled1 locationNCT05965284
Completed
Phase 4
The response of vasculitis patients to influenza vaccination compared to healthy individuals
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Royal Adelaide Hospital100 enrolled1 locationACTRN12608000440325